Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?
about
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerHigh ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patientsQuantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization.Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis.
P2860
Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Current data of targeted thera ...... empiricism or evidence-based?
@ast
Current data of targeted thera ...... empiricism or evidence-based?
@en
type
label
Current data of targeted thera ...... empiricism or evidence-based?
@ast
Current data of targeted thera ...... empiricism or evidence-based?
@en
prefLabel
Current data of targeted thera ...... empiricism or evidence-based?
@ast
Current data of targeted thera ...... empiricism or evidence-based?
@en
P2093
P2860
P1476
Current data of targeted thera ...... empiricism or evidence-based?
@en
P2093
Fausto Petrelli
Mara Ghilardi
Mary Cabiddu
Sandro Barni
P2860
P304
P356
10.1517/13543780903222268
P407
P577
2009-10-01T00:00:00Z